We will infuse synthetic human parathyroid hormone 1-34 (teriparatide acetate) to assess hypocalcemic syndromes and measure the renal response through cAMP and phosphate excretion. Results will be compared to published values to aid pseudohypoparathyroidism, and other hypocalcemic states.
Showing the most recent 10 out of 674 publications